Morgan Stanley Reiterates Underweight and PT of $1.50 on Hansen Medical

by Emily Austin, Benzinga Staff Writer
August 4, 2011 8:56 AM | 12 seconds read |
Morgan Stanley reiterated its Underweight rating on Hansen Medical HNSN. At the same time, the rating agency left its price target on the company's stock unchanged at $1.50. On Wednesday, HNSN closed the day at $4.14.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: ReiterationAnalyst RatingsHealth CareHealth Care EquipmentMorgan Stanley
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!